The miR-15 family enhances the radiosensitivity of breast cancer cells by targeting G2 checkpoints

Radiation Research

Volumn 183, Issue 2, 2015, Pages 196-207

  Mei, Zijie ^a   Su, Tingshi ^a   Ye, Junjie ^a   Yang, Chunxu ^a   Zhang, Shimin ^a   Xie, Conghua ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT KINASE 1; MICRORNA; MICRORNA 15; MICRORNA 15A; MICRORNA 15B; MICRORNA 16; NOCODAZOLE; PROTEIN BCL 2; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; MIRN15 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; BREAST CANCER CELL LINE; CELL PROLIFERATION; CLONOGENIC ASSAY; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; FLOW CYTOMETRY; FOLLOW UP; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE; IONIZING RADIATION; LUCIFERASE ASSAY; M PHASE CELL CYCLE CHECKPOINT; MTT ASSAY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RADIATION EXPOSURE; RADIOSENSITIVITY; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA ISOLATION; WESTERN BLOTTING; BREAST NEOPLASMS; FEMALE; GENETICS; MCF 7 CELL LINE; PATHOLOGY; RADIATION DOSE; RADIATION RESPONSE; TREATMENT OUTCOME; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; G2 PHASE CELL CYCLE CHECKPOINTS; HUMANS; MCF-7 CELLS; MICRORNAS; RADIATION TOLERANCE; RADIOTHERAPY DOSAGE; TREATMENT OUTCOME;

EID: 84923306742     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR13784.1     Document Type: Article

References (42)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62:10-29.
2. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998; 273:5858-68.
3. Sedelnikova OA, Pilch DR, Redon C, Bonner WM. Histone H2AX in DNA damage and repair. Cancer Biol Ther 2003; 2:233-5.
4. Rothkamm K, Lobrich M. Evidence for a lack of DNA doublestrand break repair in human cells exposed to very low x-ray doses. Proc Natl Acad Sci U S A 2003; 100:5057-62.
5. Bourton EC, Plowman PN, Smith D, Arlett CF, Parris CN. Prolonged expression of the c-H2AX DNA repair biomarker correlates with excess acute and chronic toxicity from radiotherapy treatment. Int J Cancer 2011; 129:2928-34.
6. Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature 2000; 408:433-9.
7. Maity A, McKenna WG, Muschel RJ. The molecular basis for cell cycle delays following ionizing radiation: a review. Radiother Oncol 1994; 31:1-13.
8. Chetty C, Bhoopathi P, Rao JS, Lakka SS. Inhibition of matrix metalloproteinase-2 enhances radiosensitivity by abrogating radiation-induced FoxM1-mediated G2/M arrest in A549 lung cancer cells. Int J Cancer 2009; 124:2468-77.
9. Carrassa L, Broggini M, Erba E, Damia G. Chk1, but not Chk2, is involved in the cellular response to DNA damaging agents: differential activity in cells expressing or not p53. Cell Cycle 2004; 3:1177-81.
10. Bucher N, Britten CD. G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer. Br J Cancer 2008; 98:523-8.
11. Guo CJ, Pan Q, Li DG, Sun H, Liu BW. Novel regulation of checkpoint kinase 1: is checkpoint kinase 1 a good candidate for anti-cancer therapy?. Cancer Sci 2012; 103:1195-200.
12. Hu B, Zhou XY, Wang X, Zeng ZC, Iliakis G, Wang Y. The radioresistance to killing of A1-5 cells derives from activation of the Chk1 pathway. J Biol Chem 2001; 276(21):17693-8.
13. PosthumaDeBoer J, Wurdinger T, Graat HC, van Beusechem VW, Helder MN, van Royen BJ, et al. WEE1 inhibition sensitizes osteosarcoma to radiotherapy. BMC Cancer 2011; 11:156.
14. Chaudhry MA, Kreger B, Omaruddin RA. Transcriptional modulation of micro-RNA in human cells differing in radiation sensitivity. Int J Radiat Biol 2010; 86:569-83.
15. Chaudhry MA, Omaruddin RA, Kreger B, de Toledo SM, Azzam EI. Micro RNA responses to chronic or acute exposures to low dose ionizing radiation. Mol Biol Rep 2012; 39:7549-58.
16. Bandi N, Zbinden S, Gugger M, Arnold M, Kocher V, Hasan L. miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Res 2009; 69:5553-9.
17. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 2005; 102:13944-9.
18. Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S, et al. miR-15b and miR-16 modulate multidrug resistance by targeting BCL-2 in human gastric cancer cells. Int J Cancer 2008; 123:372-9.
19. Liu Q, Fu H, Sun F, Zhang H, Tie Y, Zhu J, et al. miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res 2008; 36:5391-404.
20. Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc 2006; 1:2315-9.
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-Time quantitative PCR and the 2(-nnC(T)) method. Methods 2001; 25:402-8.
22. Shin S, Cha HJ, Lee EM, Lee SJ, Seo SK, Jin HO, et al. Alteration of miRNA profiles by ionizing radiation in A549 human non-small cell lung cancer cells. Int J Oncol 2009; 35:81-6.
23. Josson S, Sung SY, Lao K, Chung LW, Johnstone PA. Radiation modulation of microRNA in prostate cancer cell lines. Prostate 2008; 68:1599-606.
24. Karlsson-Rosenthal C, Millar JB. Cdc25: mechanisms of checkpoint inhibition and recovery. Trends Cell Biol 2006; 16:285-92.
25. Wang XC, Du LQ, Tian LL, Wu HL, Jiang XY, Zhang H, et al. Expression and function of miRNA in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer. Lung Cancer 2011; 72:92-9.
26. Salim H, Akbar NS, Zong D, Vaculova AH, Lewensohn R, Moshfegh A, et al. Mirna-214 modulates radiotherapy response of non-small cell lung cancer cells through regulation of p38mapk, apoptosis and senescence. Br J Cancer 2012; 107:1361-73.
27. Janaki Ramaiah M, Lavanya A, Honarpisheh M, Zarea M, Bhadra U, Bhadra MP. miR-15/16 complex targets p70S6 kinase1 and controls cell proliferation in MDA-MB-231 breast cancer cells. Gene 2014; 552:255-64.
28. Lin J, Liu C, Gao F, Mitchel REJ, Zhao LQ, Yang YY, et al. miR-200c enhances radiosensitivity of human breast cancer cells. J Cell Biochem 2013; 114:606-15.
29. Kato M, Paranjape T, Ullrich R, Nallur S, Gillespie E, Keane K, et al. The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells. Oncogene 2009; 28:2419-24.
30. Polytarchou C, Iliopoulos D, Struhl K. An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state. Proc Natl Acad Sci U S A 2012; 109:14470-5.
31. Camphausen K, Brady KJ, Burgan WE, Cerra MA, Russell JS, Bull EEA, et al. Flavopiridol enhances human tumor cell radiosensitivity and prolongs expression of gammaH2AX foci. Mol Cancer Ther 2004; 3:409-16.
32. Munshi A, Tanaka T, Hobbs ML, Tucker SL, Richon VM, Meyn RE. Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci. Mol Cancer Ther 2006; 5:1967-74.
33. Landsverk KS, Patzke S, Rein ID, Stokke C, Lyng H, De Angelis PM, et al. Three independent mechanisms for arrest in G2 after ionizing radiation. Cell Cycle 2011; 10:819-29.
34. Yang J, Cao Y, Sun J, Zhang Y. Curcumin reduces the expression of bcl-2 by upregulating mir-15a and mir-16 in mcf-7 cells. Med Oncol 2010; 27:1114-8.
35. Chen G, Zhu W, Shi DZ, Lv L, Zhang C, Liu P, et al. MicroRNA-181a sensitizes human malignant glioma U87MG cells to radiation by targeting Bcl-2. Oncol Rep 2010; 23:997-1003.
36. Wang X, Ma Z, Xiao Z, Liu H, Dou Z, Feng X, et al. Chk1 knockdown confers radiosensitization in prostate cancer stem cells. Oncol Rep 2012; 28:2247-54.
37. Yang H, Yoon SJ, Jin J, Choi SH, Seol HJ, Lee JI, et al. Inhibition of checkpoint kinase 1 sensitizes lung cancer brain metastases to radiotherapy. Biochem Biophys Res Commun 2011; 406:53-8.
38. Ghiasi N, Habibagahi M, Rosli R, Ghaderi A, Yusoff K, Hosseini A, et al. Tumour suppressive effects of WEE1 gene silencing in breast cancer cells. Asian Pac J Cancer P 2013; 14:6605-11.
39. Pouliot LM, Chen YC, Bai J, Guha R, Martin SE, Gottesman MM, et al. Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 Family. Cancer Res 2012; 72:5945-55.
40. Gagou ME, Zuazua-Villar P, Meuth M. Enhanced H2AX phosphorylation, DNA replication fork arrest, and cell death in the absence of Chk1. Mol Biol Cell 2010; 21:739-52.
41. Murrow LM, Garimella SV, Jones TL, Caplen NJ, Lipkowitz S. Identification of WEE1 as a potential molecular target in cancer cells by RNAi screening of the human tyrosine kinome. Breast Cancer Res Tr 2010; 122:347-57.
42. Busby EC, Leistritz DF, Abraham RT, Karnitz LM, Sarkaria JN. The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1. Cancer Res 2000; 60:2108-12.